PMHS
Polomar Health Services, Inc.
Key Financials
Operating Income
$-10550264
↓ 711.9%
Net Income
$-10701105
↓ 697.8%
Revenue
$648231
↑ 1002.0%
Gross Profit
$460099
↑ 1388.8%
EPS (Diluted)
$-0.39
↓ 680.0%
Total Liabilities
$1.6M
↑ 19.2%
Shareholders' Equity
$-1222329.00
↓ 114.2%
Total Assets
$390043.00
↓ 96.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-Q | 5/18/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| 10-K | 5/6/2026 | View on SEC |
| 8-K | 4/29/2026 | View on SEC |
| NT 10-K | 4/1/2026 | View on SEC |
| DEFM14C | 3/12/2026 | View on SEC |
| DEF 14C | 2/17/2026 | View on SEC |
| PRER14C | 2/17/2026 | View on SEC |
| PRE 14C | 2/5/2026 | View on SEC |
| 424B3 | 12/19/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PMHS |
| Company Name | Polomar Health Services, Inc. |
| CIK | 1265521 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 800-490-7454 |